guidance.fyi
Company, ticker, metric, guidance, or anything said

Concalls & earnings callsCamlin Fine Sciences Limited

Every summarised call, newest first. Latest is Q1 FY27, held 11 Aug 2026.

Latest quarter

Q1 FY27 snapshot

Open full brief →

Revenue growth was strong, but margins were severely impacted by geopolitical raw material costs, which the company expects to partially recover over the next two quarters.

MetricThis quarterChangeFive-quarter trend
Revenue₹519.9 Cr28%
EBITDA Margin4%—
Specialty Ingredients Revenue>₹400 Cr—
Specialty Ingredients EBITDA Margin6.35%—
Latest guidance
  • Revenue for the full year expected to be INR2,200-2,300 crores.
  • Full-year EBITDA margin expected to be in the range of 10-12%.
  • Aroma (vanillin) segment expected to be EBITDA positive in Q2 FY27.
  • All three business verticals expected to show significant improvement in Q2 over Q1.
  • Company-level EBITDA margins expected to return to double digits by Q3 FY27.
  • Full-year vanillin production estimated at around 3,000 tons.
  • May require additional credit lines of INR100-200 crores for working capital.
Filed results

Reported quarterly history

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

QuarterRevenueNet profit (PAT)Basic EPS
Q3 FY25₹433.49 Cr+12.3% YoY+2.5% QoQ₹-7.47 CrLoss narrowed YoYLoss narrowed QoQ₹-0.24Loss/share narrowed YoYLoss/share narrowed QoQ
Q2 FY25₹422.97 Cr+4.2% YoY+6.9% QoQ₹-116.11 CrLoss widened YoYLoss widened QoQ₹-5.98Loss/share widened YoYLoss/share widened QoQ
Q1 FY25₹395.85 Cr-5.7% YoY-1.5% QoQ₹-34.65 CrTurned loss-making YoYLoss narrowed QoQ₹-2.03Turned negative YoYLoss/share narrowed QoQ
Q4 FY24₹401.69 Cr-5.9% YoY+4.1% QoQ₹-81.79 CrTurned loss-making YoYLoss widened QoQ₹-4.64Turned negative YoYLoss/share widened QoQ
Q3 FY24₹385.89 Cr-0.5% YoY-4.9% QoQ₹-14.28 CrTurned loss-making YoYLoss narrowed QoQ₹-0.71Turned negative YoYLoss/share narrowed QoQ
Call history
  • Q1 FY27Cautious tone

    Revenue growth was strong, but margins were severely impacted by geopolitical raw material costs, which the company expects to partially recover over the next two quarters.

    Revenue
    ₹519.9 Cr28%
    EBITDA Margin
    4%
    ChemicalsVerified brief7 guidance items